The Nasdaq Biotechnology Index rose by 1%. UroGen Pharma ADR increased by 51.92%, CureVac NV ADR rose by 37.59%, and Fortrea Holdings climbed by 15.99%. Lexeo Therapeutics fell by 9.31%, MacroGenics decreased by 9.36%, and Fate Therapeutics dropped by 9.68%Wallstreetcn·Jun 12, 2025 at 10:07 PMCVAC0.00%URGN+1.83%
Global news you need to know before the U.S. stock market opens on ThursdayWallstreetcn·Jun 12, 2025 at 01:00 PMCVAC0.00%
The Nasdaq Biotechnology Index rose by 1.55%. Among the constituent stocks, Akero Therapeutics increased by 22.71%, Sana Biotechnology rose by 22.02%, and 89bio climbed by 20.97%. COVID-19 vaccine concept stock CureVac NV ADR rose by 10.47%, while Moderna increased by 6.31%. In contrast, Anavex Life Sciences fell by 9.95%, Prime Medicine dropped by 15.01%, and Alumis decreased by 16.89%Wallstreetcn·May 20, 2025 at 08:48 PMCVAC0.00%AKRO0.00%
